MECP2 and Rett syndrome: Using the improved Nme2-ABE variants, we found that we can address common disease-causing point mutations such as certain MeCP2 Rett syndrome alleles [(c.502 C > T; p.R168X) and (c.916 C > T, p.R306C)] with minimal bystander editing.